These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9237961)

  • 21. Assessment of the nutritional effects of olestra.
    J Nutr; 1997 Aug; 127(8 Suppl):1539S-1728S. PubMed ID: 9273390
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of olestra and sorbitol consumption on objective measures of diarrhea: impact of stool viscosity on common gastrointestinal symptoms.
    McRorie J; Zorich N; Riccardi K; Bishop L; Filloon T; Wason S; Giannella R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):59-67. PubMed ID: 10715225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: olestra and its gastrointestinal safety.
    Thomson AB; Hunt RH; Zorich NL
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1185-200. PubMed ID: 9882026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olestra ingestion and retinyl palmitate absorption in humans.
    Daher GC; Cooper DA; Zorich NL; King D; Riccardi KA; Peters JC
    J Nutr; 1997 Aug; 127(8 Suppl):1686S-1693S. PubMed ID: 9237963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 14 d of covert substitution of olestra for conventional fat on spontaneous food intake.
    Hill JO; Seagle HM; Johnson SL; Smith S; Reed GW; Tran ZV; Cooper D; Stone M; Peters JC
    Am J Clin Nutr; 1998 Jun; 67(6):1178-85. PubMed ID: 9625091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olestra, a nonabsorbed, noncaloric replacement for dietary fat: a review.
    Lawson KD; Middleton SJ; Hassall CD
    Drug Metab Rev; 1997 Aug; 29(3):651-703. PubMed ID: 9262944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olestra: a new food additive.
    Prince DM; Welschenbach MA
    J Am Diet Assoc; 1998 May; 98(5):565-9. PubMed ID: 9597030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of wheat bran and Olestra on objective measures of stool and subjective reports of GI symptoms.
    McRorie J; Kesler J; Bishop L; Filloon T; Allgood G; Sutton M; Hunt T; Laurent A; Rudolph C
    Am J Gastroenterol; 2000 May; 95(5):1244-52. PubMed ID: 10811335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the effects of dilution of dietary energy with olestra on energy intake.
    Jandacek RJ
    Physiol Behav; 2012 Mar; 105(5):1124-31. PubMed ID: 22222110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial.
    Sandler RS; Zorich NL; Filloon TG; Wiseman HB; Lietz DJ; Brock MH; Royer MG; Miday RK
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):253-61. PubMed ID: 10068382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olestra consumption is not associated with macular pigment optical density in a cross-sectional volunteer sample in Indianapolis.
    Cooper DA; Curran-Celentano J; Ciulla TA; Hammond BR; Danis RB; Pratt LM; Riccardi KA; Filloon TG
    J Nutr; 2000 Mar; 130(3):642-7. PubMed ID: 10702598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 20-month olestra feeding study in dogs.
    Miller KW; Wood FE; Stuard SB; Alden CL
    Food Chem Toxicol; 1991 Jul; 29(7):427-35. PubMed ID: 1894209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ingesting olestra-based foods on feeding behavior and energy balance in humans.
    Stubbs RJ
    Crit Rev Food Sci Nutr; 2001 Jul; 41(5):363-86. PubMed ID: 11497329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy.
    Beckey NP; Korman LB; Parra D
    Pharmacotherapy; 1999 Sep; 19(9):1075-9. PubMed ID: 10610014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olestra snacks compared with regular snacks.
    Jacobson MF
    Ann Intern Med; 1999 Dec; 131(11):866. PubMed ID: 10610637
    [No Abstract]   [Full Text] [Related]  

  • 36. Decreased carotenoid concentrations due to dietary sucrose polyesters do not affect possible markers of disease risk in humans.
    Broekmans WM; Klöpping-Ketelaars IA; Weststrate JA; Tijburg LB; van Poppel G; Vink AA; Berendschot TT; Bots ML; Castenmiller WA; Kardinaal AF
    J Nutr; 2003 Mar; 133(3):720-6. PubMed ID: 12612143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olestra formulation and the gastrointestinal tract.
    Jandacek RJ; Kester JJ; Papa AJ; Wehmeier TJ; Lin PY
    Lipids; 1999 Aug; 34(8):771-83. PubMed ID: 10529087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in diet, weight, and serum lipid levels associated with olestra consumption.
    Patterson RE; Kristal AR; Peters JC; Neuhouser ML; Rock CL; Cheskin LJ; Neumark-Sztainer D; Thornquist MD
    Arch Intern Med; 2000 Sep; 160(17):2600-4. PubMed ID: 10999973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal symptoms following consumption of olestra or regular triglyceride potato chips: a controlled comparison.
    Cheskin LJ; Miday R; Zorich N; Filloon T
    JAMA; 1998 Jan; 279(2):150-2. PubMed ID: 9440666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for olestra in body weight management.
    Eldridge AL; Cooper DA; Peters JC
    Obes Rev; 2002 Feb; 3(1):17-25. PubMed ID: 12119656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.